EPO and anemia: Intravenous L-carnitine (LC) following dialysis can replenish the free carnitine removed from the blood and restore muscle carnitine content, alleviating muscle myopathies and impaired exercise capacity [13], as well as ameliorating erythropoietin-resistant anemia, decreased cardiac performance, intradialytic hypotension [54].